Topic: Ron Cohen
Acorda Therapeutics, (ACOR) Q3 2010 Earnings Call November 01, 2010 8:00 am ET. With me today are Dr. Ron Cohen, our President and Chief Executive Officer; and David Lawrence, our Chief Financial Officer and Lauren Sabella, our Executive Vice President of ...
Acorda Therapeutics, Inc. (Nasdaq: ACOR ) on Monday morning released financial results that easily beat Wall Street expectations.. . Acorda...
Acorda Therapeutics, Inc. (ACOR) Q2 2010 Earnings Call August 03, 2010 8:30 am ET. With me today are Dr. Ron Cohen, our President and Chief Executive Officer; and David Lawrence, our Chief Financial Officer.. These statements are subject to risks and ...
Acorda Therapeutics, Inc. (ACOR) Q1 2010 Earnings Call Transcript April 30, 2010 8:30 am ET. With me today are Dr. Ron Cohen, our President and Chief Executive Officer and David Lawrence, our Chief Financial Officer. These statements are subject to risks ...
FDA approves Ampyra as first drug to aid walking in multiple sclerosis patientsFederal health regulators have approved an Acorda Therapeutics pill to improve walking in patients multiple sclerosis, an often disabling disease that affects the nervous system.The Food and Drug Administration ...
A BRAWL OVER PRESCRIPTION DATA IMS Health has built a lucrative niche collecting data on which drugs physicians prescribe, then selling the information to pharmaceutical companies. The Supreme Court could shine a spotlight on this topic in the next few weeks if ...
The world is changing. A tax evader should seriously consider what may be the only way to stop an illegal bad situation from becoming a life-destroying criminal prosecution. Consider a Voluntary Disclosure to clean-up the past. Based on tax law precedent going ...
That Franchise Tax Board (FTB) has begun mailing notices (FTB 4106 MEO) to taxpayers who meet the mandatory e-pay threshold. The new mandatory e-pay law requires taxpayers to remit their payments electronically if their tax liability exceeds $80,000, or they made ...
Through the early 1990s, there was significant dispute over the U.S. tax classification of a foreign legal entity. Foreign legal entities have characteristics that often differ from U.S. legal entities which U.S. taxpayers are accustom to, like corporations, partnerships ...
Cohen's company is working on a Fampridine-SR, a multiple sclerosis treatment, which is expected to be filed for approval with the FDA early next year.. The FDA's delays in meeting deadlines for some approval decisions and as well as in ...